47th Annual UNC Lineberger Postdoctoral/Faculty Research Day

UNC Lineberger’s 47th Annual Postdoctoral/Faculty Research Day is open to all UNC Lineberger graduate students, postdocs and faculty members.

This year’s event, hosted by the CRTEC program, will feature:

• A keynote from Norman E. “Ned” Sharpless, MD
• Research talks by selected postdoctoral fellows
• Judged poster sessions for graduate students and postdocs, followed by ample time at the end of the day reserved for networking and open discussions

More information about the event will be posted as it becomes available, including the full event schedule (anticipated early September).

Registration

• Graduate students and postdocs interested in presenting research posters must submit an abstract by September 9, 2022. The most competitive poster presentations will be awarded cash prizes.
• General registration (i.e. no abstract) will extend through October.

Registration

Note: A small number of postdoctoral abstracts will be selected for research talks; all postdocs who give a talk instead of presenting a poster will also receive a cash prize.

About the keynote speaker

Ned Sharpless, MD, served as director of the National Cancer Institute (NCI) from October 2017 until April 2022. He also served as Acting Commissioner for Food and Drugs at the U.S. Food and Drug Administration (FDA) in 2019. Prior to his role as NCI director, Sharpless was the director of the UNC Lineberger Comprehensive Cancer Center, a position he held from 2014 until 2017. Sharpless has long been a member of the UNC-Chapel Hill community; matriculating as an undergraduate student in mathematics, he earned distinction as a Morehead-Cain Scholar and subsequently undertook his medical studies at the School of Medicine, receiving an MD in 1993. Sharpless continued his training at Harvard Medical School, completing an internal medicine residency at the Massachusetts General Hospital as well as a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, after which he became a member of the faculty, first at Harvard Medical School in 2000 and two years later at the UNC School of Medicine, where he joined the Departments of Medicine and Genetics. In 2012, Sharpless was named the Wellcome Professor of Cancer Research. During his directorship at NCI, Sharpless championed initiatives to address health equity as well as diversity in the cancer research workforce, notably leading the creation of NCI’s Equity and Inclusion Program in 2020. In addition to being an ardent advocate of continued support for investigator-initiated research in cancer, he crucially helped launch important data science programs including the Childhood Cancer Data Initiative.